Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/1996
11/19/1996US5576321 Compounds having effects on serotonin-related systems
11/19/1996US5576320 1-heteruarylazetidines and -pyrrolidines, process for their preparation and pharmaceutical compositions containing them
11/19/1996US5576318 For treatment of central nervous system disorders
11/19/1996US5576317 NK-1 receptor antagonists and 5HT3 receptor antagonists for the treatment of emesis
11/19/1996US5576316 Method for inhibiting tumor growth rate using creatine or creatine analogs
11/19/1996US5576313 Enzyme inhibitors and anticarcinogenic agents
11/19/1996US5576312 1-azatricyclo[7.2.0.03,8 ]undec-2-ene-2-carboxylates as antibacterial compounds
11/19/1996US5576311 Cyclodextrins as suspending agents for pharmaceutical suspensions
11/19/1996US5576309 Estradiol derivative-chlorambucil conjugate, process for preparing the same, and pharmaceutical composition
11/19/1996US5576306 Pharmaceutical compositions and uses of water-soluble, high-viscosity grade cellulose ethers
11/19/1996US5576305 Intercellular adhesion mediators
11/19/1996US5576304 Antithrombotic composition
11/19/1996US5576293 Inhibitors of farnesyl-protein transferase
11/19/1996US5576287 Method for treating acute renal disease and failure
11/19/1996US5576025 Gastrointestinal mucosa-adherent matrixes, pharmaceutical preparations and a coating composition
11/19/1996US5576024 Buffered matrix aspirin
11/19/1996US5576022 Controlled release tacrine drug delivery systems and methods for preparing same
11/19/1996US5576021 Hypotensive agents
11/19/1996US5576015 Substantially purified beta (1,3) finely ground yeast cell wall glucan composition with dermatological and nutritional uses
11/19/1996US5576005 Viricides and topical treatment
11/19/1996US5576001 Of carrots, rice, bananas and glucose
11/19/1996US5575993 Useful as herbicides, microbiocides, plant growth regulators, pharmaceuticals, disinfectants, algicides, sanitizers, and preservatives
11/19/1996US5575988 Combination sunscreen and insect repellent
11/19/1996US5575652 Process for applying antibacterial oral composition to dental implant areas
11/19/1996CA2176414A1 Acyl guanidine and amidine prodrugs
11/19/1996CA2111460C Tetrahydrobenzazepine derivatives which inhibit lipoxygenase
11/19/1996CA2109613C Fluoroalkoxybenzylamino derivatives of nitrogen containing heterocycles
11/19/1996CA2106200C Stereoselective preparation of substituted piperidines
11/18/1996CA2176415A1 Benzo-fused azepinone and piperidinone compounds useful in the inhibition of ace and nep
11/17/1996CA2176553A1 Fluorine-containing benzoylguanidines
11/17/1996CA2176185A1 Stable microemulsions of certain 3-isothiazolone compounds
11/14/1996WO1996035953A1 Combinatorial synthesis and high-throughput screening of a rev-inhibiting arylidenediamide array
11/14/1996WO1996035805A2 Tripeptidylpeptidase inhibitors
11/14/1996WO1996035793A1 Animal gene therapy
11/14/1996WO1996035787A1 Nucleic acids for treating obesity
11/14/1996WO1996035782A1 Il-6 activity inhibitor
11/14/1996WO1996035720A1 Heavy metal salts of succinic acid hemiesters with hyaluronic acid, or hyaluronic acid esters, a process for their preparation, and relative pharmaceutical compositions
11/14/1996WO1996035708A1 Fibroblast growth factor homologous factor-1 (fhf-1) and methods of use
11/14/1996WO1996035707A1 Terpenoid inhibitors of farnesyl-protein transferase
11/14/1996WO1996035702A1 Dialkyltiacumicin compounds
11/14/1996WO1996035701A1 Antibiotics
11/14/1996WO1996035700A1 Saccharopeptides and derivatives thereof
11/14/1996WO1996035698A1 Antimalarial organometallic iron complexes
11/14/1996WO1996035692A1 Antibacterial cephalosporins
11/14/1996WO1996035691A1 Spirocyclic and bicyclic diazinyl and carbazinyl oxazolidinones
11/14/1996WO1996035689A1 Novel deazapurine derivatives; a new class of crf1 specific ligands
11/14/1996WO1996035687A1 Peptidyl compounds and their therapeutic use
11/14/1996WO1996035681A1 Benzothiazoles and benzoxazoles, as well as drugs containing them, their use and methods of preparing them
11/14/1996WO1996035678A1 Alpha-substituted pyrimidine-thioalkyl and alkylether compounds as inhibitors of viral reverse transcriptase
11/14/1996WO1996035677A1 Nitric oxide synthase inhibitors derived from cyclic amidines
11/14/1996WO1996035671A1 β-ADRENERGIC AGONISTS
11/14/1996WO1996035670A1 β-ADRENERGIC AGONISTS
11/14/1996WO1996035667A1 Alpha-(substituted alkylphenyl)-4-(hydroxydiphenylmethyl)-1-piperidine butanol derivatives, their preparation and their use as anti-histamines, anti-allergy agents and bronchodilators
11/14/1996WO1996035666A1 Benzyl piperidine derivatives as pharmaceutical agents
11/14/1996WO1996035661A1 Surfactants containing quaternary-nitrogen groups
11/14/1996WO1996035453A2 Endothelin antagonists and endothelin synthase inhibitors for the prevention and treatment of interine contractility disorders, preeclampsia, atherosclerotic vascular disease, hypertension and or hormone replacement therapy
11/14/1996WO1996035452A1 Pharmaceutical composition containing acetylcysteine, carbocysteine or erdosteine in combination with a beta 2 agonist and an expectorant for the treatment of respiratory tract disorders
11/14/1996WO1996035446A1 Treatment of alzheimer disease by modulation of synapsins
11/14/1996WO1996035445A1 The use of epidermal growth factor as a gastrointestinal therapeutic agent
11/14/1996WO1996035441A1 Pharmaceutical compositions for the treatment of alcohol addiction
11/14/1996WO1996035440A1 Pharmaceutical composition comprising lactobacillus plantarum and arginine
11/14/1996WO1996035436A1 Compositions comprising bismuth and one or more antimicrobials, for the treatment and prevention of gastrointestinal disorders
11/14/1996WO1996035435A1 Compositions containing bismuth, for the treatment and prevention of gastrointestinal disorders
11/14/1996WO1996035433A1 N,o-carboxymethylchitosan for prevention of surgical adhesions
11/14/1996WO1996035430A1 REMEDY AND PREVENTIVE FOR DISEASES CAUSED BY NF-λB
11/14/1996WO1996035429A1 Use of non-steroidal anti-inflammatory agents to improve the physiological compatibility of particular pharmaceutical preparations
11/14/1996WO1996035428A1 Pharmaceutical compositions containing steroid derivatives involved in triggering an immune response
11/14/1996WO1996035427A1 Transdermal therapeutic system for administering testosterone
11/14/1996WO1996035426A1 Compounds useful for concurrently activating glucocorticoid-induced response and reducing multidrug resistance
11/14/1996WO1996035425A1 A pharmaceutical composition useful in treating alcohol dependence or abuse comprising at least one partial agonist of 5-th1a receptors and at least one selective inhibitor of monoamino-oxidase
11/14/1996WO1996035424A1 Aryl-imidazolines and aryl-imidazoles useful as alpha-2 adrenergic agonists without cardiovascular side effects
11/14/1996WO1996035423A1 Antifungal composition
11/14/1996WO1996035422A1 Methods for inhibiting bone loss
11/14/1996WO1996035421A1 High-dose chromic tripicolinate for the treatment of type ii diabetes
11/14/1996WO1996035420A1 Use of(s)-enantiomers of 1,4-dihydropyridine derivatives for treating heart failure
11/14/1996WO1996035419A1 Combination of methotrexate and tenidap for the treatment of rheumatoid arthritis
11/14/1996WO1996035418A1 Method for inhibiting the binding of selectins to sialyl-lewises
11/14/1996WO1996035417A1 Combinations of anti-oestrogen compounds and pkc modulators and their use in cancer therapy
11/14/1996WO1996035416A1 Localized use of nitric oxideadducts to prevent internal tissue damage
11/14/1996WO1996035415A2 Use of sesquiterpenes for inhibiting oxidative enzymes
11/14/1996WO1996035407A1 Prevention of tooth loss by the administration of alendronate or its salts
11/14/1996WO1996031208A3 Use of substituted piperidine or pyrrolidine compounds for treating sigma-receptor modulated disorders
11/14/1996WO1996028148A3 Use of a r-nsaid in a protective composition for the treatment of colorectal cancer
11/14/1996WO1996027008A3 Agent for treating tumours and other hyperplasia
11/14/1996WO1996024378A3 Delivery of exogenous compounds
11/14/1996WO1996022068A3 Methods and pharmaceutical compositions employing desmethylselegiline
11/14/1996WO1996015148A3 Low molecular weight peptidomimetic growth hormone secretagogues
11/14/1996DE19518221A1 Verwendung nichtsteroidaler Entzündungshemmer zur Verbesserung der physiologischen Verträglichkeit partikulärer pharmazeutischer Zubereitungen Use of non-steroidal anti-inflammatory drugs to improve the physiological tolerance particulate pharmaceutical preparations
11/14/1996DE19517448A1 Neue Benzothiazole und Benzoxazole, diese Verbindungen enthaltende Arzneimittel und deren Verwendung sowie Verfahren zu ihrer Herstellung New benzothiazoles and benzoxazoles, pharmaceutical compositions containing them and their use, and processes for their preparation
11/14/1996DE19517251A1 Use of D-(+) pantothenyl-alcohol to treat dry nose
11/14/1996CA2221035A1 Tripeptidylpeptidase inhibitors
11/14/1996CA2220897A1 Treatment of alzheimer disease by modulation of synapsins
11/14/1996CA2220893A1 Fibroblast growth factor homologous factor-1 (fhf-1) and methods of use
11/14/1996CA2220771A1 Antibiotics
11/14/1996CA2220677A1 Endothelin antagonists and endothelin synthase inhibitors for the prevention and treatment of uterine contractility disorders, preeclampsia, atherosclerotic vascular disease, hypertension and for hormone replacement therapy
11/14/1996CA2220576A1 Combinatorial synthesis and high-throughput screening of a rev-inhibiting arylidenediamide array
11/14/1996CA2220538A1 .beta.-adrenergic agonists
11/14/1996CA2220517A1 Aryl-imidazolines and aryl-imidazoles useful as alpha-2 adrenergic agonists without cardiovascular side effects
11/14/1996CA2220508A1 Saccharopeptides and derivatives thereof
11/14/1996CA2220504A1 Benzyl piperidine derivatives as pharmaceutical agents